GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Supriya Lifescience Ltd (BOM:543434) » Definitions » Tax Expense

Supriya Lifescience (BOM:543434) Tax Expense : ₹631 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Supriya Lifescience Tax Expense?

Supriya Lifescience's tax expense for the months ended in Dec. 2024 was ₹158 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹631 Mil.


Supriya Lifescience Tax Expense Historical Data

The historical data trend for Supriya Lifescience's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Supriya Lifescience Tax Expense Chart

Supriya Lifescience Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Expense
Get a 7-Day Free Trial 228.24 437.16 554.35 336.30 465.76

Supriya Lifescience Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.12 162.43 151.31 159.15 157.97

Supriya Lifescience Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹631 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Supriya Lifescience  (BOM:543434) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Supriya Lifescience Tax Expense Related Terms

Thank you for viewing the detailed overview of Supriya Lifescience's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Supriya Lifescience Business Description

Traded in Other Exchanges
Address
Sonawala Road, 207/208, Udyog Bhavan, Goregaon East, Mumbai, MH, IND, 400063
Supriya Lifescience Ltd is a manufacturer of Active pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.

Supriya Lifescience Headlines

No Headlines